Cargando…
Dysautonomia in Parkinson’s Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control
Evidence from clinical practice suggests that PD patients with the Glucocerebrosidase gene mutations (GBA-PD) are characterized by more severe dysautonomic symptoms than patients with idiopathic PD (iPD). Therefore, an accurate assessment of cardiovascular autonomic control (CAC) is necessary to cla...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964968/ https://www.ncbi.nlm.nih.gov/pubmed/35368256 http://dx.doi.org/10.3389/fnins.2022.842498 |
_version_ | 1784678329140379648 |
---|---|
author | Carandina, Angelica Lazzeri, Giulia Rodrigues, Gabriel Dias Franco, Giulia Monfrini, Edoardo Arienti, Federica Frattini, Emanuele Trezzi, Ilaria da Silva Soares, Pedro Paulo Bellocchi, Chiara Furlan, Ludovico Montano, Nicola Di Fonzo, Alessio Tobaldini, Eleonora |
author_facet | Carandina, Angelica Lazzeri, Giulia Rodrigues, Gabriel Dias Franco, Giulia Monfrini, Edoardo Arienti, Federica Frattini, Emanuele Trezzi, Ilaria da Silva Soares, Pedro Paulo Bellocchi, Chiara Furlan, Ludovico Montano, Nicola Di Fonzo, Alessio Tobaldini, Eleonora |
author_sort | Carandina, Angelica |
collection | PubMed |
description | Evidence from clinical practice suggests that PD patients with the Glucocerebrosidase gene mutations (GBA-PD) are characterized by more severe dysautonomic symptoms than patients with idiopathic PD (iPD). Therefore, an accurate assessment of cardiovascular autonomic control (CAC) is necessary to clarify the role of GBA mutations in the pathophysiology of PD. We evaluated the CAC at rest and during orthostatic challenge of 15 iPD, 15 GBA-PD and 15 healthy controls (CTR). ECG and respiration were recorded in supine position and during active standing. The analysis of Heart Rate Variability (HRV) was performed on ECG recordings using two different approaches, linear spectral analysis and non-linear symbolic analysis. GBA-PD patients presented more frequently an akinetic-rigid phenotype and cognitive dysfunction than iPD patients. Both iPD and GBA-PD group were characterized by a lower spectral HRV than CTR group. At rest, the GBA-PD group was characterized by a lower parasympathetic modulation and a shift of the sympathovagal balance toward a sympathetic predominance compared to the CTR group. Moreover, the GBA-PD patients presented a lower HR increment and a lower or absent reduction of the vagal modulation in response to the active standing than iPD patients. Lastly, the cardiovascular autonomic dysfunction in PD patients was associated with longer disease duration, and with the occurrence of REM sleep behavior disorder and constipation. Our findings suggest a more severe impairment of the CAC in PD patients with GBA mutations. These results and further studies on the role of GBA mutations could allow a stratification based on cardiovascular risk in PD patients and the implementation of specific prevention programs. |
format | Online Article Text |
id | pubmed-8964968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89649682022-03-31 Dysautonomia in Parkinson’s Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control Carandina, Angelica Lazzeri, Giulia Rodrigues, Gabriel Dias Franco, Giulia Monfrini, Edoardo Arienti, Federica Frattini, Emanuele Trezzi, Ilaria da Silva Soares, Pedro Paulo Bellocchi, Chiara Furlan, Ludovico Montano, Nicola Di Fonzo, Alessio Tobaldini, Eleonora Front Neurosci Neuroscience Evidence from clinical practice suggests that PD patients with the Glucocerebrosidase gene mutations (GBA-PD) are characterized by more severe dysautonomic symptoms than patients with idiopathic PD (iPD). Therefore, an accurate assessment of cardiovascular autonomic control (CAC) is necessary to clarify the role of GBA mutations in the pathophysiology of PD. We evaluated the CAC at rest and during orthostatic challenge of 15 iPD, 15 GBA-PD and 15 healthy controls (CTR). ECG and respiration were recorded in supine position and during active standing. The analysis of Heart Rate Variability (HRV) was performed on ECG recordings using two different approaches, linear spectral analysis and non-linear symbolic analysis. GBA-PD patients presented more frequently an akinetic-rigid phenotype and cognitive dysfunction than iPD patients. Both iPD and GBA-PD group were characterized by a lower spectral HRV than CTR group. At rest, the GBA-PD group was characterized by a lower parasympathetic modulation and a shift of the sympathovagal balance toward a sympathetic predominance compared to the CTR group. Moreover, the GBA-PD patients presented a lower HR increment and a lower or absent reduction of the vagal modulation in response to the active standing than iPD patients. Lastly, the cardiovascular autonomic dysfunction in PD patients was associated with longer disease duration, and with the occurrence of REM sleep behavior disorder and constipation. Our findings suggest a more severe impairment of the CAC in PD patients with GBA mutations. These results and further studies on the role of GBA mutations could allow a stratification based on cardiovascular risk in PD patients and the implementation of specific prevention programs. Frontiers Media S.A. 2022-03-15 /pmc/articles/PMC8964968/ /pubmed/35368256 http://dx.doi.org/10.3389/fnins.2022.842498 Text en Copyright © 2022 Carandina, Lazzeri, Rodrigues, Franco, Monfrini, Arienti, Frattini, Trezzi, da Silva Soares, Bellocchi, Furlan, Montano, Di Fonzo and Tobaldini. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Carandina, Angelica Lazzeri, Giulia Rodrigues, Gabriel Dias Franco, Giulia Monfrini, Edoardo Arienti, Federica Frattini, Emanuele Trezzi, Ilaria da Silva Soares, Pedro Paulo Bellocchi, Chiara Furlan, Ludovico Montano, Nicola Di Fonzo, Alessio Tobaldini, Eleonora Dysautonomia in Parkinson’s Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control |
title | Dysautonomia in Parkinson’s Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control |
title_full | Dysautonomia in Parkinson’s Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control |
title_fullStr | Dysautonomia in Parkinson’s Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control |
title_full_unstemmed | Dysautonomia in Parkinson’s Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control |
title_short | Dysautonomia in Parkinson’s Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control |
title_sort | dysautonomia in parkinson’s disease: impact of glucocerebrosidase gene mutations on cardiovascular autonomic control |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964968/ https://www.ncbi.nlm.nih.gov/pubmed/35368256 http://dx.doi.org/10.3389/fnins.2022.842498 |
work_keys_str_mv | AT carandinaangelica dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT lazzerigiulia dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT rodriguesgabrieldias dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT francogiulia dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT monfriniedoardo dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT arientifederica dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT frattiniemanuele dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT trezziilaria dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT dasilvasoarespedropaulo dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT bellocchichiara dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT furlanludovico dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT montanonicola dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT difonzoalessio dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol AT tobaldinieleonora dysautonomiainparkinsonsdiseaseimpactofglucocerebrosidasegenemutationsoncardiovascularautonomiccontrol |